Status:
ENROLLING_BY_INVITATION
Predictive Factors and Monitoring Strategies in Steroid-Induced Diabetes
Lead Sponsor:
Medical University of Warsaw
Conditions:
Steroid-Induced Diabetes
Diabete Type 2
Eligibility:
All Genders
18+ years
Brief Summary
Glucocorticoids are widely used in the management of autoimmune, inflammatory and neoplastic conditions. However, they are associated with significant metabolic effects, including steroid-induced diab...
Detailed Description
Approximately 250 patients hospitalised at Warsaw University Hospital will be enrolled. Baseline data collection includes medical history, anthropometry, HbA1c, and basic biochemical tests. CGM sensor...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adults (≥18 years of age)
- No prior diagnosis of diabetes
- Planned initiation of oral and/or intravenous glucocorticoid therapy for non-substitutive indications
- Informed consent
- Exclusion criteria:
- Age \<18 years
- History of diabetes or use of antidiabetic medications
- GC therapy within the past 6 months
- Replacement therapy for primary or secondary adrenal insufficiency, pituitary insufficiency, Nelson's syndrome, or congenital adrenal hyperplasia
- Lack of consent
Exclusion
Key Trial Info
Start Date :
June 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 19 2028
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07190378
Start Date
June 20 2025
End Date
June 19 2028
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
Warsaw, Warsaw, Poland, 02-097